On ‘Psychology Behind the Headlines,’ hosts Patricia Wu, Jessica Reyes, and guest Aaron Seibert, Executive Director of PTSD Foundation of America and Road to Hope radio show host, discuss how MDMA may become a FDA approved for PTSD treatment.
FDA Review
The FDA is evaluating MDMA as a potential treatment for PTSD, marking a significant shift in the perception of psychedelic substances.
Potential Benefits
Research suggests MDMA may help patients with PTSD feel more open and less fearful during therapy.
Responsible Use
Experts emphasize the importance of controlled doses and careful monitoring for any potential treatment involving MDMA.
